UBS Group
NAGE

UBS Group’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.23M Buy
85,656
+30,520
+55% +$440K ﹤0.01% 4190
2025
Q1
$380K Buy
55,136
+10,663
+24% +$73.6K ﹤0.01% 4873
2024
Q4
$236K Sell
44,473
-14,416
-24% -$76.5K ﹤0.01% 5162
2024
Q3
$215K Sell
58,889
-80,857
-58% -$295K ﹤0.01% 4649
2024
Q2
$382K Buy
139,746
+119,723
+598% +$327K ﹤0.01% 4116
2024
Q1
$69.7K Buy
20,023
+18,570
+1,278% +$64.6K ﹤0.01% 5205
2023
Q4
$2.08K Buy
1,453
+394
+37% +$563 ﹤0.01% 6955
2023
Q3
$1.55K Sell
1,059
-5,467
-84% -$7.98K ﹤0.01% 6753
2023
Q2
$10.2K Sell
6,526
-11,089
-63% -$17.4K ﹤0.01% 6069
2023
Q1
$27K Buy
17,615
+206
+1% +$315 ﹤0.01% 5778
2022
Q4
$29.2K Sell
17,409
-6,500
-27% -$10.9K ﹤0.01% 6094
2022
Q3
$29K Sell
23,909
-516
-2% -$626 ﹤0.01% 5847
2022
Q2
$41K Buy
24,425
+2,750
+13% +$4.62K ﹤0.01% 5060
2022
Q1
$53K Sell
21,675
-33,334
-61% -$81.5K ﹤0.01% 5424
2021
Q4
$206K Buy
55,009
+2,389
+5% +$8.95K ﹤0.01% 4620
2021
Q3
$330K Sell
52,620
-46,801
-47% -$294K ﹤0.01% 3963
2021
Q2
$980K Buy
99,421
+48,617
+96% +$479K ﹤0.01% 3266
2021
Q1
$474K Sell
50,804
-101,490
-67% -$947K ﹤0.01% 3972
2020
Q4
$731K Buy
152,294
+1,694
+1% +$8.13K ﹤0.01% 3379
2020
Q3
$604K Sell
150,600
-51,281
-25% -$206K ﹤0.01% 3271
2020
Q2
$926K Sell
201,881
-18,538
-8% -$85K ﹤0.01% 2885
2020
Q1
$719K Sell
220,419
-17,505
-7% -$57.1K ﹤0.01% 2925
2019
Q4
$1.03M Buy
237,924
+27,971
+13% +$121K ﹤0.01% 3318
2019
Q3
$826K Buy
209,953
+16,264
+8% +$64K ﹤0.01% 3339
2019
Q2
$900K Sell
193,689
-1,261
-0.6% -$5.86K ﹤0.01% 3118
2019
Q1
$817K Buy
194,950
+42,607
+28% +$179K ﹤0.01% 3059
2018
Q4
$523K Buy
152,343
+7,281
+5% +$25K ﹤0.01% 3474
2018
Q3
$623K Sell
145,062
-642
-0.4% -$2.76K ﹤0.01% 3507
2018
Q2
$541K Buy
145,704
+24,292
+20% +$90.2K ﹤0.01% 3487
2018
Q1
$510K Buy
121,412
+58,848
+94% +$247K ﹤0.01% 3449
2017
Q4
$368K Buy
62,564
+27,564
+79% +$162K ﹤0.01% 3653
2017
Q3
$151K Buy
35,000
+21,691
+163% +$93.6K ﹤0.01% 4187
2017
Q2
$51K Sell
13,309
-6,174
-32% -$23.7K ﹤0.01% 4715
2017
Q1
$52K Buy
19,483
+182
+0.9% +$486 ﹤0.01% 4605
2016
Q4
$64K Buy
19,301
+6,301
+48% +$20.9K ﹤0.01% 4736
2016
Q3
$39K Sell
13,000
-2,932
-18% -$8.8K ﹤0.01% 4846
2016
Q2
$66K Buy
+15,932
New +$66K ﹤0.01% 4473